Related Experiment Video
Updated: Jul 4, 2025

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
Published on: September 22, 2017
Recurrent MECR R258W causes adult-onset optic atrophy: A case report
Nan Jia1, Shuiqing Yu2, Geng Zhang2
1Department of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Abstract:
MECR-related neurologic disorder, also known as mitochondrial enoyl CoA reductase protein-associated neurodegeneration (MEPAN) or dystonia with optic atrophy and basal ganglia abnormalities in childhood (MIM: #617282), is an autosomal recessive inherited disease characterized by a progressive childhood-onset movement disorder and optic atrophy. Here we report a 19-year-old male, presented with progressive visual failure, nystagmus, and right orbital pain, with no history of movement or eye disorder in his childhood. His visual decline started at age 18 years, whereas nystagmus emerged seven months later. Analysis of whole-exome sequencing (WES) revealed a homozygous recurrent variant (NM_016011.5:c.772C > T, p.Arg258Trp) in MECR. These findings suggest phenotypic heterogeneity in MECR-related neurologic disorder, thus, more relevant case screening, will help to delineate the genotype-phenotype correlation of the MECR gene.
Insights
MECR-related neurologic disorder, a rare inherited condition, typically presents in childhood. This study highlights a case with adult-onset symptoms, expanding the known disease spectrum.
Area of Science:
- Genetics
- Neurology
- Ophthalmology
Background:
- MECR-related neurologic disorder (MEPAN) is an autosomal recessive inherited disease.
- Characterized by childhood-onset movement disorder and optic atrophy.
- Previous cases typically present with early-onset symptoms.
More Related Videos
09:37A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023